Home Cart Sign in  
Chemical Structure| 5465-86-1 Chemical Structure| 5465-86-1

Structure of ML204
CAS No.: 5465-86-1

Chemical Structure| 5465-86-1

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

ML204 is a selective antagonist of TRPC4 ion channel with IC50 of 0.96 μM and 2.6 μM in fluorescent and electrophysiological assays respectively.

Synonyms: CID-230710; NSC 25850; 2-piperidino-Lepidine

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of ML204

CAS No. :5465-86-1
Formula : C15H18N2
M.W : 226.32
SMILES Code : CC1=CC(N2CCCCC2)=NC3=CC=CC=C13
Synonyms :
CID-230710; NSC 25850; 2-piperidino-Lepidine
MDL No. :MFCD00817920
InChI Key :USYRQXDHKXGTCK-UHFFFAOYSA-N
Pubchem ID :230710

Safety of ML204

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
Ulva compressa 10 μM 12 h To detect copper-induced membrane depolarization events Front Plant Sci. 2016 Jun 14;7:754
mouse CA1 pyramidal cells 10 µM 15 minutes To test the inhibitory effect of ML204 on persistent firing, results showed that ML204 significantly inhibited persistent firing Cells. 2020 Feb 5;9(2):365

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice CFA-induced unilateral arthritis model Intraperitoneal 2 mg/kg Daily for 14 days Chronic TRPC5 antagonism exacerbated arthritis inflammation and hyperalgesia Ann Rheum Dis. 2017 Jan;76(1):252-260
C57BL/6 mice Chronic constriction of the unilateral infraorbital nerve (CION) model Intraperitoneal injection 2 mg/kg/day Once daily for 11 days ML204 significantly alleviated CION-induced pain behaviors, including mechanical allodynia, non-evoked nociceptive responses, and cold allodynia symptoms. CNS Neurosci Ther. 2025 Apr;31(4):e70368
CD1 mice and 129 S1/SvIm mice Carrageenan-induced inflammation model Intraperitoneal injection 4 mg/kg 30 minutes before pretreatment ML204 failed to prevent the anti-inflammatory and analgesic effects of EA, indicating that EA's effects are independent of TRPC4/5 Int J Mol Sci. 2021 Jun 15;22(12):6380
Mice High-sucrose diet-induced metabolic imbalance model Subcutaneous injection 2 mg/kg Once daily for 7 days To assess the effects of ML204 on high-sucrose diet-induced metabolic imbalances. Results showed that ML204 exacerbated hyperglycaemia, dyslipidaemia, fat tissue deposition, hepatic steatosis, and adipose tissue and liver TNFα levels in HS-fed mice. Pharmaceuticals (Basel). 2023 Aug 3;16(8):1100
Mice TRPC1 knockout mice and wildtype mice Bath superfusion 20 µM and 50 µM To compare the inhibitory effects of ML204 on 1S,3R-ACPD-induced plateau potentials in TRPC1 knockout mice and wildtype mice. Results showed that ML204 consistently inhibited plateau potentials in TRPC1 knockout mice, while its effects in wildtype mice were complex, with some neurons completely unaffected and others fully blocked. Pharmaceuticals (Basel). 2023 Sep 13;16(9):1291
Rats Chronic intrathecal catheter model Intrathecal injection 10 µg Single administration ML-204 significantly attenuated mechanical hypersensitivity induced by netrin-1 during the early phase but had no significant effect during the late phase. Int J Mol Sci. 2022 Jun 14;23(12):6629

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

4.42mL

0.88mL

0.44mL

22.09mL

4.42mL

2.21mL

44.19mL

8.84mL

4.42mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories